Archive: 02/06/2017
Immune responses from early study of novel sarcoma vaccine
The critical component of an experimental vaccine led to an escalating immune response in patients with sarcoma, an indicator of its potential anti-cancer effects.
Jun 2, 2017
Secukinumab and ixekizumab in psoriasis: Considerable added benefit for certain patients
Psoriasis is an incurable chronic disease with a hereditary component, in which the body's immune system attacks parts of the skin. This leads to scaly red patches, which can be very itchy. About two million people in Germany ...
Jun 2, 2017